SUMO1 antibody
Quick Overview for SUMO1 antibody (ABIN6297549)
Target
See all SUMO1 AntibodiesReactivity
Host
Clonality
Conjugate
Application
-
-
Purpose
- Mouse anti-Human/Mouse/Rat SUMO1 Antibody [Sodium Azide Free]
-
Specificity
- Predominantly nuclear with some cytoplasmic
-
Purification
- Recombinant human protein was used as the immunogen for this SUMO1 antibody.
-
Immunogen
- Recombinant human protein was used as the immunogen for this SUMO1 antibody.
-
-
-
-
Application Notes
-
FACS: 0.5-1 μg/million cells
IF: 0.5-1 μg/mL
WB: 0.5-1 μg/mL
IHC (FFPE): 0.5-1 μg/mL for 30 minutes at RT (1)
Prediluted format: incubate for 30 min at RT (2) -
Restrictions
- For Research Use only
-
-
-
Buffer
- In 1X PBS ( pH 7.4), BSA free, sodium azide free
-
Preservative
- Azide free
-
Storage
- 4 °C,-20 °C
-
Storage Comment
- 2-8°C. The azide-free format should be aliquoted and stored at -20°C or colder.
-
-
- SUMO1 (Small Ubiquitin Related Modifier Protein 1 (SUMO1))
-
Alternative Name
- Small ubiquitin-related modifier 1
-
Background
-
Target Description: The small ubiquitin-related modifier (SUMO) proteins, which include SUMO1, 2 and 3, belong to the ubiquitin-like protein family. Like ubiquitin, the SUMO proteins are synthesized as precursor proteins that undergo processing before conjugation to target proteins. However, SUMO and ubiquitin differ with respect to targeting. Ubiquitination predominantly targets proteins for degradation, whereas sumoylation targets proteins to a variety of cellular processing, including nuclear transport, transcriptional regulation, apoptosis and protein stability.
Gene Symbol: SUMO1///SMT3C///SMT3H3///UBL1///OK///SW-cl.43
-
Gene ID
- 7341
-
UniProt
- P63165
-
Pathways
- M Phase, Positive Regulation of Endopeptidase Activity, Protein targeting to Nucleus, Ubiquitin Proteasome Pathway
Target
-